Author:
Sher Theo,McGee Michelle,DuCoin Christopher,Sujka Joseph,Docimo Salvatore
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Stierman B, Afful J, Carroll MD, Chen TC, Davy O, Fink S, Fryar CD, Gu Q, Hales CM, Hughes JP, Ostchega Y, Storandt RJ, Akinbami LJ, National Center for Health Statistics (U.S.). National health and nutrition examination survey 2017–march 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes. Natl Health Stat Report. 2021. https://stacks.cdc.gov/view/cdc/106273.
2. Ward ZJ, Bleich SN, Long MW, Gortmaker SL. Association of body mass index with health care expenditures in the United States by age and sex. PLoS One. 2021;16(3):e0247307. PubMed PMID: 33760880. Pubmed Central PMCID: PMC7990296. Epub 20210324. eng.
3. Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov. 2006;5(11):919–31. PubMed PMID: 17080028. eng.
4. Sargent BJ, Moore NA. New central targets for the treatment of obesity. Br J Clin Pharmacol. 2009;68(6):852–60. PubMed PMID: 20002079. Pubmed Central PMCID: PMC2810796. eng.
5. •• Vosburg RW, El Chaar M, El Djouzi S, Docimo S Jr, Choi D, LaMasters T, et al. Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. Surg Obes Relat Dis. 2022;18(9):1109–19. PubMed PMID: 36028428. Epub 20220714. eng. This review summarizes the anti-obesity pharmacotherapy options that available for use in bariatric surgery patients. It is highly relevant to the current review which analyzes publications on the topic of pharmacotherapy use in bariatric surgery patients.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献